Pfizer Licenses Oxford Bio's Gene Therapy Know-How

Gene therapy specialist Oxford BioMedica said on Monday that Pfizer had licensed its gene delivery technology, triggering an unspecified upfront payment and annual fees.

()a href="http://www.reuters.co.uk/financeArticle.jhtml;jsessionid=42JCWXLLS5X4QCRBAEZSFFA?type=stocksAndSharesNews&storyID=746293" target="_blank">Reuters